Biosplice Therapeutics
Small Molecules Acting on Stem Cells. Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
6
Funding Rounds
$799.0m
Money raised
Overview
Small Molecules Acting on Stem Cells. Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
- Website:
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Biosplice Therapeutics has raised a total of $799m in funding over 6 rounds.
Key Insights:
- Biosplice Therapeutics Venture round, April 15, 2021: $120m
- Biosplice Therapeutics Series B round, August 6, 2018: $438m
- Biosplice Therapeutics Series D round, January 1, 2018: $21m
- Biosplice Therapeutics Series A round, September 1, 2013: $220m
Biosplice Therapeutics Venture round, April 15, 2021
$120m
Biosplice Therapeutics Series B round, August 6, 2018
$438m
Biosplice Therapeutics Series D round, January 1, 2018
$21m
Biosplice Therapeutics Series A round, September 1, 2013
$220m
Industries
Biosplice Therapeutics is active in the following industries: